We have used site-directed spin labeling and pulsed dipolar electron-electron paramagnetic resonance (DEER) to resolve the structure and dynamics of flexible and disordered regions of myosin binding protein-C (MyBP-C)'s cardiac isoform, with implications for the pathophysiology of hypertrophic cardiomyopathy (HCM). N-terminal domains of cMyBP-C contain binding domains for several interaction partners in the myofilament, including myosin heavy chain subfragment 2 (S2) and actin. We engineered pairs of labeling sites in protein fragments of mouse cMyBP-C to measure with high resolution distance and disorder between (1) domains C0 and C1, flanking the flexible Pro/Ala-rich linker, and between (2) domains C1 and C2, flanking the partially disordered phosphorylation motif, using DEER. Changes in distance and disorder were assessed for double-Cys mutant cMyBP-C's free in solution and when bound to myosin S2 or actin, with or without cMyBP-C phosphorylation by protein kinase A (PKA). Understanding conformational transitions in the flexible and dynamic portions of cMyBP-C upon actin-myosin binding and phosphorylation provide new molecular insight into defining its modulatory role in muscle force development. (NIH-F32 to BAC; NIH-R01 to DDT) Obscurins, encoded by the single OBSCN gene, comprise a family of giant (~890-810 kDa) and small (~550-50 kDa) proteins of vertebrate striated muscles composed of adhesion and signaling motifs. Giant obscurins intimately surround sarcomeres at the level of M-bands and Z-disks where they participate in the assembly, stabilization, and integration of the contractile cytoskeleton with other sarcoplasmic structures. Consistent with this, the immunoglobulin (Ig) domains 58 and 59 of obscurins interact directly with Ig domains 9 and 10 of titin located at the periphery of Z-disks. Genomic linkage analysis has recently revealed a missense mutation (R4344Q) in obscurin Ig58 that is causally linked to hypertrophic cardiomyopathy (HCM). To examine how the R4344Q mutation leads to the development of HCM, we generated two animal models: a knock-in model that contains full length obscurins carrying the R4344Q mutation, and a partial knock-out model that lacks Ig 58 and 59. Immunoblot and immunofluorescence analysis indicated that both mutant and truncated obscurins are readily expressed in cardiac muscles, and properly incorporated into sarcomeres. Homozygous partial knock-out mice developed overt cardiac hypertrophy by 12 months of age, as measured by echocardiography; notably, hypertrophy was exacerbated in the female homozygous animals. While a hypertrophic trend was apparent in homozygous knock-in animals, phenotypic and functional alterations of the affected hearts were not statistically significant from those of wild-type animals. Importantly, trans-aortic constriction of 2 months old knock-in and partial knock-out male and female mice led to severe cardiac hypertrophy within 4-8 weeks post-surgery, as evaluated by echocardiography. We are currently examining the cellular and biochemical manifestations of mutant and truncated obscurins, as related to the development of HCM. Our studies provide the first in vivo models to study the molecular defects that underlie HCM due to altered obscurins. University of Oxford, Oxford, United Kingdom. A novel homozygous mutation in the TNNT2 gene encoding cardiac troponin T (cTnT K280N) was identified in one HCM patient undergoing cardiac transplantation. mRNA and Mass Spectrometry analyses revealed expression of the mutant alleles without evidence of haploinsufficiency. Kinetics of contraction and relaxation of myofibrils from a frozen left ventricular sample of the K280N HCM patient were compared to those of ''control'' myofibrils (from donor hearts, from aortic stenosis patients, and from HCM patients negative for sarcomeric protein mutations). Preparations, mounted in a force recording apparatus (15 C), were maximally Ca 2þ -activated (pCa 4.5) and fully relaxed (pCa 9) by rapid (<10 ms) solution switching. The rate constant of active tension generation following maximal Ca 2þ activation (k ACT ) was markedly faster in K280N myofibrils (ca. 1.7 s À1 ) compared to controls (0.7-1 s À1 ). The rate constant of isometric relaxation (slow k REL ) was 2-3-fold faster in K280N myofibrils than in controls, evidence that the apparent rate with which cross-bridges leave the force generating states is accelerated in the mutant preparations. The results suggest that the energy cost of tension generation is increased in the K280N sarcomeres. Simultaneous measurements of maximal isometric ATPase and Ca 2þ -activated force in Triton-permeabilized left ventricular muscle strips from the K280N sample demonstrated that tension cost was much higher in the K280N than in control myocardium. Replacement of the mutant protein by exchange with wild-type recombinant human Tn in the K280N myofibrils reduced both k ACT and slow k REL close to control values. This indicates that the HCM-associated TNNT2 mutation K280N primarily alters apparent cross-bridge kinetics and impairs sarcomere energetics. Supported by the 7th Framework Program of the European Union, ''BIG-HEART'' grant agreement 241577. A naturally occurring proteolytic N-terminal truncation of cardiac troponin I (cTnI-ND) has been shown to compensate for functional abnormalities caused by cardiomyopathic mutations. A proteolytic N-terminal truncation of cardiac TnT (cTnT-ND) elongates ventricular ejection time to compensate for cardiac output against high pressure load. To investigate the mechanisms for these troponin modifications to modulate the function of cardiac muscle thin filament, we produced transgenic mouse lines co-expressing cTnI-ND and/or cTnT-ND with a family hypertrophic cardiomyopathy mutation of cardiac a-tropomyosin (TM-E180G). The over expression of TM-E180G resulted in~90% replacement of endogenous a-tropomyosin in the cardiac muscle with normal total stoichiometry. Functional studies in ex vivo working hearts of 2-monthold TM-E180G mice showed lower diastolic velocity and higher left ventricular diastolic pressure, indicating higher Ca 2þ sensitivity. b-MHC expression together with myocardial fibrosis was found in the left ventricle of 28-day and 2-month-old TM-E180G mice with early failing phenotypes (lower stroke volume and lower systolic velocity). In double and triple transgenic mouse hearts, expression of cTnI-ND and/or cTnT-ND decreased the occurrence of b-MHC in TM-E180G mouse hearts. Functional studies showed cTnINDþcTnT-ND did not override the contractile phenotype of TM E180G mutation but had beneficial effects on improving stroke volume and reducing fibrosis, with additive effects in the triple transgenic hearts. While TM-E180G mice usually die between 4 and 5 months of age, cardiac function of TM-E180GþcTnI-NDþcTnT-ND triple transgenic mice remained apparently normal at 10-11 months of age as shown by the compensated heart function and cardiac efficiency with minimal b-MHC occurrence. These results demonstrated compensatory effects of posttranslational modifications of troponin on the functional abnormality of tropomyosin for potential applications in the treatment of heart failure.
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Effects of Cardiomyopathy-Related Troponin T Mutations on the Ubiquitin-Proteasome System Jennifer E. Gilda, Ziyou Cui, Shannamar Dewey, Aldrin V. Gomes. University of California, Davis, Davis, CA, USA. Familial hypertrophic cardiomyopathy (FHC) is a disease of the myocardium that can be caused by a mutation in a sarcomeric gene. TNNT2 encodes cardiac troponin T (cTnT), a sarcomeric protein important for cardiac muscle contraction. Mutations in TNNT2 are frequently linked to sudden cardiac death (SCD); however their role in heart failure and cardiomyopathy is unclear. We hypothesize that changes in the ubiquitin-proteasome system (UPS) are related to increased risk of cardiac death, and that changes in the UPS may be related to calcium sensitization caused by TNNT2 mutations. We examined two mutations in TNNT2, R278C, which is associated with mild effects and late-onset heart disease, and the calcium-sensitizing mutation I79N, which is earlyonset and has severe cardiac effects, including SCD. In 3-month-old transgenic mice expressing the I79N mutant form of troponin T, expression of the proteasome subunit PSMA6 was decreased by approximately 35% in I79N mice when compared to hearts from wild-type transgenic mice. Protein levels of the 19S regulator subunit Rpt1 were increased in the hearts of 3-month-old I79N mice and decreased in the hearts of 1-year-old R278C mice. Expression of PKC alpha, an important regulator of cardiac contractility, was decreased in R278C mice at 1 year. Activity of the lysosomal protease cathepsin L was increased in 1-year-old I79N mice, indicating disruption of another major proteolytic system in these hearts. Quantitative real-time PCR of the genes involved in the ubiquitination pathway (E1, E2, and E3 enzymes) showed that transcript levels were increased or decreased for 25 genes in I79N mice and three genes in R278C mice. These data demonstrate that the UPS is affected at the gene expression and protein level in R278C and I79N mice, indicating that changes in the UPS may be involved in FHC. The transition-path is the tiny fraction of an equilibrium, single-molecule trajectory when a transition occurs between two states. The importance of the transition-path in protein folding is that it contains all the mechanistic information on how a protein folds and unfolds. However, a transition-path has never been observed experimentally for any molecular system in the condensed phase because it is too fast to measure. Even determining the average transition-path time, ht TP i, is challenging. Previously, we determined ht TP i~2ms for the allb protein, FBP28 WW-domain (1/k F =100ms) and an upper bound of ht TP i~10ms for the much slower ab-protein GB1 (1/k F =1s) by employing the GopichSzabo maximum likelihood analysis of photon trajectories in single-molecule FRET experiments and a kinetic model in which the lifetime of an additional state in a one-step discretization of the transition path corresponds to ht TP i (Chung et al., Science 2012) . Surprisingly, the ht TP is for the two proteins differ by <5-fold, while the folding rates differ by~10,000-fold. Even more surprising is that this result can be explained by the theory for diffusion of a Brownian particle over a barrier on a one-dimensional free-energy surface, which predicts ht TP i to be insensitive to the barrier height but to scale as 1/D*, the diffusion coefficient at the barrier top, i.e. ht TP imln(3bDG*)/D*. Maximum likelihood analysis of photon trajectories for a 3 D, an all-a protein (1/k F =2ms), reveals an additional-state lifetime of 12ms. While the folding time for all-b proteins scales linearly with the solvent viscosity, like other all-a proteins, the folding time of a 3 D scales sub-linearly with viscosity (1/k F~h 1/2 ), as does the 12ms lifetime. These results indicate that this additional lifetime corresponds to ht TP i, slowed compared to the WW-domain by a larger contribution of internal friction to D*.
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966-Plat Insight into the Molecular Origins of the Internal Friction in Unfolded Proteins
Ignacia Echeverria 1 , Dmitrii E. Makarov 2 , Garegin Papoian 1 . 1 University of Maryland, College Park, MD, USA, 2 University of Texas at Austin, Austin, TX, USA. Protein folding and dynamics can be modeled as a diffusional process on a lowdimensional free energy surface. Contributions to this dissipative process can be separated into solvent dependent or wet friction and internal or dry friction, where frictional effects are due to the chain itself. Experimental evidence and polymer models (Soranno, A. et al., Proc. Natl. Acad. Sci. USA, 2012) have shown that the internal friction is an additive contribution to the reconfiguration time of unfolded proteins. Despite recent advances, the molecular origins of these effects have remained largely elusive. Using extensive all-atom molecular dynamics simulations we studied the dynamics of the unfolded cold-shock protein (CSP) from Thermotoga maritima at different solvent viscosities and at different denaturant concentrations (including the denaturant free case). Reconfiguration times obtained from MD simulations are consistent with experimental results. Also, in agreement with experimental results, simulations done at different denaturant concentrations suggest that the internal friction contribution correlates with the compactness of the unfolded protein. We used diffusion map analysis to characterize the slow diffusive variables and cluster the states sampled during each simulation. We systematically analyzed the reconfiguration dynamics of relevant structural features such as hydrogen bonds formation (native and non-native) and dihedral angle rotations. By defining the relaxation timescale of these structural features we were able to identify their contributions into the internal friction in the unfolded state. These results have important implications for the folding kinetics of proteins especially when considering protein folding in the context of the denaturant-free environment of a living cell. Under these conditions, the internal friction contribution may be dominant in the folding process.
967-Plat Two-Dimensional Infrared Spectroscopy as a Probe of Protein Folding:
Bridging the Gap between Experiment and Simulation Carlos Baiz, Chunte Sam Peng, Mike Reppert, Kevin C. Jones, Andrei Tokmakoff. Massachussetts Institute of Technology, Cambridge, MA, USA. Two-dimensional infrared (2DIR) spectroscopy is a newly-developed experimental technique that measures protein structure and dynamics in solution with subpicosecond time resolution. Amide-I vibrations, consisting mainly of backbone C=O stretching modes, contain a wealth of structural information. Two-dimensional spectroscopy offers enhanced structural sensitivity by spreading the spectral information onto two frequency axes. Through a combination of temperature-jump 2DIR spectroscopy, isotope labeling, and Markov state models derived from molecular dynamics simulations, we develop a new method which can directly probe the structural rearrangements on timescales from nanoseconds to milliseconds. Markov state models provide an intuitive interpretation of the protein folding process while retaining much of the structural heterogeneity and diversity of folding pathways. The unfolding mechanism of a 39-residue a/b mini protein, NTL9, a two-state folder, is studied on timescales from 100 ns to 50 milliseconds. Transient 2DIR reveal a rapid sub-100 ns response that is attributed to weakening of the hydrogen-bonds, followed by unraveling of the beta sheet. The more stable helix is seen to denature on the 150 microsecond timescale. Experimental data is interpreted in the context of the recently-available Markov state model of NTL9. Simulated 2DIR spectra are generated for the structural ensemble, and are observed to be in great agreement with the temperature-jump 2DIR experiments. The results provide an elegant illustration of how a combination of cutting-edge experiments and state-of-the-art simulations gives new insights into the complex mechanism of protein folding. Temperature jump experiments have been used to study the kinetics of protein folding for over 20 years. These experiments have driven our understanding of protein folding and our attempts to simulate protein dynamics. It may be easier, however, to model and understand the effect of pressure perturbations on proteins because pressure affects biomolecular structure only through density changes, not through changes of thermal energy or solvent composition. In 2009 our lab was the first to report a pressure drop apparatus, which could be used to change the pressure of a protein solution from 2500 atm to 1 atm in less than a microsecond, causing the proteins to fold. We have recently used that instrument to study the refolding of a mutant of a protein called lambda repressor fragment 6-85 (l* 6-85 ). l* 6-85 is one of the fastest folding proteins ever discovered, with all of its known mutants folding in less than 50 ms. Surprisingly, we have observed a slow (~1 ms) phase in the refolding of a mutant of l* 6-85 initiated by a fast pressure drop. The emergence of this slow timescale highlights the necessity of expanding our toolbox for studying the dynamics of protein folding, as it may be that only certain conformations are populated by manipulation of a single thermodynamic variable.
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The Effects of Crowding and Osmolytes on the Temperature-Pressure Stability and Intermolecular Interactions of Proteins Roland Winter. TU Dortmund University, Dortmund, Germany. Mechanisms have evolved in nature that allow living organisms to deal with extreme environmental conditions by producing organic osmolytes. For example, certain marine organisms living in the deep sea have evolved a surprising simple mechanism to counteract the deleterious effects of the cellular waste product urea and of hydrostatic pressure by trimethylammonium N-oxide (TMAO). Hence, we investigated the effect of pressure on the structure and intermolecular interactions of dense lysozyme solutions in urea-TMAO mixtures using small-angle X-ray scattering in combination with a liquid-state theoretical approach based on the DLVO potential which accounts for repulsive and attractive interactions between the protein molecules. Supplementary thermodynamic information was obtained by employing calorimetric techniques, densitometry and ultrasound velocimetry. We show that the particular structural 188a
